Trial Profile
MLD-55 placebo-controlled trial against social anxiety disorder
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 15 Feb 2017
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Social phobia
- Focus Therapeutic Use
- 14 Feb 2017 New trial record